<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="uk">
		<id>http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=Teens%2C_Jobs_And_Talazoparib</id>
		<title>Teens, Jobs And Talazoparib - Історія редагувань</title>
		<link rel="self" type="application/atom+xml" href="http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=Teens%2C_Jobs_And_Talazoparib"/>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Teens,_Jobs_And_Talazoparib&amp;action=history"/>
		<updated>2026-05-04T00:34:42Z</updated>
		<subtitle>Історія редагувань цієї сторінки в вікі</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Teens,_Jobs_And_Talazoparib&amp;diff=194334&amp;oldid=prev</id>
		<title>Salebabies1: Створена сторінка: Table 5 Causes of death of HCM The survival rate was worse for patients with apical HCM, followed by those with obstructive and non obstructive septal asymmetri...</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Teens,_Jobs_And_Talazoparib&amp;diff=194334&amp;oldid=prev"/>
				<updated>2017-06-26T04:34:48Z</updated>
		
		<summary type="html">&lt;p&gt;Створена сторінка: Table 5 Causes of death of HCM The survival rate was worse for patients with apical HCM, followed by those with obstructive and non obstructive septal asymmetri...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Нова сторінка&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Table 5 Causes of death of HCM The survival rate was worse for patients with apical HCM, followed by those with obstructive and non obstructive septal asymmetric HCM and patients showing concentric HCM had the best survival rates. There are significant differences as the survival rates decline in 65% in a 9 years-period. Log rank test showed significant differences [https://en.wikipedia.org/wiki/Binedaline binedaline] (P [http://www.selleckchem.com/products/dabrafenib-gsk2118436.html see more] in 50% in [http://www.selleckchem.com/products/bmn-673.html Talazoparib] a 20 month-period. Log rank test showed significant differences (P&lt;/div&gt;</summary>
		<author><name>Salebabies1</name></author>	</entry>

	</feed>